Accord Healthcare
is a young and dynamic pharmaceutical company, involved in the development, manufacturing and distribution of pharmaceutical products to over 50 markets around the world.
Drug Reaction Report
TOGETHER WE CAN DO MORE
Accord strongly believes that commitment towards people and society as a whole positively contributes towards its business objective. We are committed to the interests of society by taking responsibility for the impact of our activities on customers, employees, communities and the environment in all aspects of our operations.
EUROPEAN FOCUS
Accord currently has a portfolio comprising nearly 5,000 marketing authorizations in Europe. We operate a pan European commercial footprint with direct presence in all major EU markets.
ACCORD AND OTHER LEADING VOICES IN THE PHARMACEUTICAL AND FINANCIAL INDUSTRY DEBATE HOW TO DRIVE CONSISTENT AND LONG-TERM GROWTH
In November 2018, at the House of Lords, Accord partnered with Generics bulletin to bring influential industry experts together at an intimate roundtable to talk about how pharma companies should drive consistent and long-term growth.
ACCORD HEALTHCARE ANNOUNCES EUROPEAN COMMISSION APPROVAL AND COMPLETION OF ITS PURCHASE OF A BASKET OF PRODUCTS FROM TEVA
Accord Healthcare is pleased to announce EC approval has been granted for its purchase of European Economic Area (EEA) rights to a basket of 13 products from TEVA.